Cargando…
Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”
BACKGROUND: The biomarker serum S100 calcium-binding protein B (S100B) is used in in-hospital triage of adults with mild traumatic brain injury to rule out intracranial lesions. The biomarker glial fibrillary acidic protein (GFAP) is suggested as a potential diagnostic biomarker for traumatic brain...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173808/ https://www.ncbi.nlm.nih.gov/pubmed/34078435 http://dx.doi.org/10.1186/s13049-021-00891-5 |
_version_ | 1783702781726556160 |
---|---|
author | Seidenfaden, Sophie-Charlott Kjerulff, Julie Linding Juul, Niels Kirkegaard, Hans Møller, Mette Fogh Münster, Anna-Marie Bloch Bøtker, Morten Thingemann |
author_facet | Seidenfaden, Sophie-Charlott Kjerulff, Julie Linding Juul, Niels Kirkegaard, Hans Møller, Mette Fogh Münster, Anna-Marie Bloch Bøtker, Morten Thingemann |
author_sort | Seidenfaden, Sophie-Charlott |
collection | PubMed |
description | BACKGROUND: The biomarker serum S100 calcium-binding protein B (S100B) is used in in-hospital triage of adults with mild traumatic brain injury to rule out intracranial lesions. The biomarker glial fibrillary acidic protein (GFAP) is suggested as a potential diagnostic biomarker for traumatic brain injury. The aim of this study was to investigate the diagnostic accuracy of early prehospital S100B and GFAP measurements to rule out intracranial lesions in adult patients with mild traumatic brain injury. METHODS: Prehospital and in-hospital blood samples were drawn from 566 adult patients with mild traumatic brain injury (Glasgow Coma Scale Score 14–15). The index test was S100B and GFAP concentrations. The reference standard was endpoint adjudication of the traumatic intracranial lesion based on medical records. The primary outcome was prehospital sensitivity of S100B in relation to the traumatic intracranial lesion. RESULTS: Traumatic intracranial lesions were found in 32/566 (5.6%) patients. The sensitivity of S100B > 0.10 μg/L was 100% (95%CI: 89.1;100.0) in prehospital samples and 100% (95% CI 89.1;100.0) in in-hospital samples. The specificity was 15.4% (95%CI: 12.4;18.7) in prehospital samples and 31.5% (27.5;35.6) in in-hospital samples. GFAP was only detected in less than 2% of cases with the assay used. CONCLUSION: Early prehospital and in-hospital S100B levels < 0.10 μg/L safely rules out traumatic intracranial lesions in adult patients with mild traumatic brain injury, but specificity is lower with early prehospital sampling than with in-hospital sampling. The very limited cases with values detectable with our assay do not allow conclusions to be draw regarding the diagnostic accuracy of GFAP. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02867137. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13049-021-00891-5. |
format | Online Article Text |
id | pubmed-8173808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81738082021-06-03 Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study” Seidenfaden, Sophie-Charlott Kjerulff, Julie Linding Juul, Niels Kirkegaard, Hans Møller, Mette Fogh Münster, Anna-Marie Bloch Bøtker, Morten Thingemann Scand J Trauma Resusc Emerg Med Original Research BACKGROUND: The biomarker serum S100 calcium-binding protein B (S100B) is used in in-hospital triage of adults with mild traumatic brain injury to rule out intracranial lesions. The biomarker glial fibrillary acidic protein (GFAP) is suggested as a potential diagnostic biomarker for traumatic brain injury. The aim of this study was to investigate the diagnostic accuracy of early prehospital S100B and GFAP measurements to rule out intracranial lesions in adult patients with mild traumatic brain injury. METHODS: Prehospital and in-hospital blood samples were drawn from 566 adult patients with mild traumatic brain injury (Glasgow Coma Scale Score 14–15). The index test was S100B and GFAP concentrations. The reference standard was endpoint adjudication of the traumatic intracranial lesion based on medical records. The primary outcome was prehospital sensitivity of S100B in relation to the traumatic intracranial lesion. RESULTS: Traumatic intracranial lesions were found in 32/566 (5.6%) patients. The sensitivity of S100B > 0.10 μg/L was 100% (95%CI: 89.1;100.0) in prehospital samples and 100% (95% CI 89.1;100.0) in in-hospital samples. The specificity was 15.4% (95%CI: 12.4;18.7) in prehospital samples and 31.5% (27.5;35.6) in in-hospital samples. GFAP was only detected in less than 2% of cases with the assay used. CONCLUSION: Early prehospital and in-hospital S100B levels < 0.10 μg/L safely rules out traumatic intracranial lesions in adult patients with mild traumatic brain injury, but specificity is lower with early prehospital sampling than with in-hospital sampling. The very limited cases with values detectable with our assay do not allow conclusions to be draw regarding the diagnostic accuracy of GFAP. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02867137. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13049-021-00891-5. BioMed Central 2021-06-02 /pmc/articles/PMC8173808/ /pubmed/34078435 http://dx.doi.org/10.1186/s13049-021-00891-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Original Research Seidenfaden, Sophie-Charlott Kjerulff, Julie Linding Juul, Niels Kirkegaard, Hans Møller, Mette Fogh Münster, Anna-Marie Bloch Bøtker, Morten Thingemann Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study” |
title | Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study” |
title_full | Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study” |
title_fullStr | Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study” |
title_full_unstemmed | Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study” |
title_short | Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study” |
title_sort | diagnostic accuracy of prehospital serum s100b and gfap in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the pretbi i study” |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173808/ https://www.ncbi.nlm.nih.gov/pubmed/34078435 http://dx.doi.org/10.1186/s13049-021-00891-5 |
work_keys_str_mv | AT seidenfadensophiecharlott diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy AT kjerulffjulielinding diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy AT juulniels diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy AT kirkegaardhans diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy AT møllermettefogh diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy AT munsterannamariebloch diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy AT bøtkermortenthingemann diagnosticaccuracyofprehospitalserums100bandgfapinpatientswithmildtraumaticbraininjuryaprospectiveobservationalmulticentercohortstudythepretbiistudy |